Back to results
US 2026/0085047 A1Published application
Triphenylazole compound
AssigneesShiratori Pharmaceutical Co., Ltd., Tohoku University
InventorsHiroshi YOSHINO, Taichi KOMODA, Masahiko ITO, Koji FUKUNAGA, Ichiro KAWAHATA
Life of this patent
Estimating the term…
Abstract
The present invention provides a compound represented by formula (I) and useful as a medicament, or a pharmaceutically acceptable salt thereof. The present invention further provides a pharmaceutical composition for the treatment or prevention of synucleinopathy.
Claims16
A compound represented by formula (IX):
- wherein R1 is a hydrogen atom or a C1-6 haloalkyl;
- R2 is a C1-6 haloalkyl;
- R3 is selected from hydroxys, C1-6 alkyls, C1-6 alkoxys and halogen atoms;
- R4 is selected from halogen atoms and C1-6 alkyls;
- R5 is a hydrogen atom or a C1-6 alkyl;
- R6 is a halogen atom or a C1-6 alkyl;
- m is an integer selected from 0 to 3;
- n is an integer selected from 0 to 3;
- p is an integer selected from 0 to 2;
- and
- Het is a 5-membered nitrogen-containing aromatic heterocyclic ring with one nitrogen atom and two carbon atoms substituted with phenyl groups,
- or a pharmaceutically acceptable salt thereof.
9 more elements
Dependencies are inferred from the claim text.